Artemisinin defeats malaria and other parasites
Artemisinin has also proven itself as a safe and effective treatment for malaria in over two million patients.
Now studies are also showing that Artemisinin is effective against a wide variety of cancers as shown in a series of successful experiments. The most effective is leukemia and colon cancer. Intermediate activities were also shown against melanoma, breast, ovarian, prostate, CNS and renal cancer.
Artemisinin's method of action
Artemisinin contains two oxygen atoms linked together in what is known as an 'endoperoxide bridge', which react with iron atoms to form free radicals. Artemisinin becomes toxic to malaria parasites when it reacts with the high iron content of the parasites, generating free radicals, and leading to damage to the parasite.
By this same mechanism, Artemisinin becomes toxic to cancer cells which sequester relatively large amounts of iron compared to normal, healthy human cells. According to the Gordon Research Institute, tests have been conducted which show that Artemisinin causes rapid and extensive damage and death in cancer cells and yet has relatively low toxicity to normal cells.